Review



phase 2 development • rexulti  (Lundbeck)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Lundbeck phase 2 development • rexulti
    Phase 2 Development • Rexulti, supplied by Lundbeck, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rexulti/2+development+phase+rexulti+%E2%80%A2/sec_filing____1430306_slash_000138713119001745_slash_ex99___01-134-73-83
    Average 86 stars, based on 1 article reviews
    phase 2 development • rexulti - by Bioz Stars, 2026-09
    86/100 stars

    Images

    Related Articles

    Bioprocessing:

    Article Title: Advancements in Pharmacological Treatment of Alzheimer’s Disease: The Advent of Disease-Modifying Therapies (DMTs)
    Article Snippet: Psychiatric Abnormalities Associated with AD , Rexulti , agitation , yes , high , Otsuka Pharmaceutical/Lundbeck , Full approval for marketing (2023).

    Article Title: Complaints about Violations of Voluntary and Pharmaceutical Industry-Run Medicine Promotion Codes in Canada
    Article Snippet: No appeal 2021 Healthcare professional vs Otsuka & Lundbeck Yes Rexulti Advertisement did not include a reference list Upheld 1 of 3 allegations No immediate action was required.

    Article Title: The action of aripiprazole and brexpiprazole at the receptor level in singultus .
    Article Snippet: 5-HT7 (Ki 5-HT ≈ 2-8): The affinity of the endogenous agonist serotonin for the 5-HT7 receptor is (strong) high 2 REXULTI® B. Otsuka and Lundbeck.

    Article Title: How the FDA approved an antipsychotic that failed to show a meaningful benefit but raised the risk of death.
    Article Snippet: 11 Apr 2014. https://www.cms.gov/Medicare/Provider-Enrollment-and-Certification/SurveyCertificationGenInfo/Policy-and-Memos-to-States-and-Regions-Items/Survey-and-Cert-Letter-14-19 2 DeArment A. Otsuka/Lundbeck’s Rexulti has time to build a lead in the Alzheimer’s agitation market.



    Similar Products

    phase 2 development • rexulti  (Lundbeck)
    86
    Lundbeck phase 2 development • rexulti
    Phase 2 Development • Rexulti, supplied by Lundbeck, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rexulti/2+development+phase+rexulti+%E2%80%A2/sec_filing____1430306_slash_000138713119001745_slash_ex99___01-134-73-83
    Average 86 stars, based on 1 article reviews
    phase 2 development • rexulti - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    brexpiprazole (rexulti)  (Lundbeck)
    90
    Lundbeck brexpiprazole (rexulti)
    Comparison of each neuropsychiatric symptom of patients with AD and general patients.
    Brexpiprazole (Rexulti), supplied by Lundbeck, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rexulti/brexpiprazole+rexulti/pmc11547068-264-0-6
    Average 90 stars, based on 1 article reviews
    brexpiprazole (rexulti) - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    rexulti  (Lundbeck)
    90
    Lundbeck rexulti
    New drugs for Alzheimer’s disease.
    Rexulti, supplied by Lundbeck, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rexulti/rexulti/pmc11506318-20-6-15
    Average 90 stars, based on 1 article reviews
    rexulti - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    rexulti® (brexpiprazole)  (Lundbeck)
    90
    Lundbeck rexulti® (brexpiprazole)
    New drugs for Alzheimer’s disease.
    Rexulti® (Brexpiprazole), supplied by Lundbeck, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rexulti/brexpiprazole+rexulti/pm38924384-182-9-9
    Average 90 stars, based on 1 article reviews
    rexulti® (brexpiprazole) - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    brexpiprazole (rexulti)  (MultiTarget Pharmaceuticals)
    90
    MultiTarget Pharmaceuticals brexpiprazole (rexulti)
    New drugs for Alzheimer’s disease.
    Brexpiprazole (Rexulti), supplied by MultiTarget Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rexulti/brexpiprazole++rexulti+/pm37114423-28-8-5
    Average 90 stars, based on 1 article reviews
    brexpiprazole (rexulti) - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Comparison of each neuropsychiatric symptom of patients with AD and general patients.

    Journal: International Journal of Molecular Sciences

    Article Title: Future Therapeutic Strategies for Alzheimer’s Disease: Focus on Behavioral and Psychological Symptoms

    doi: 10.3390/ijms252111338

    Figure Lengend Snippet: Comparison of each neuropsychiatric symptom of patients with AD and general patients.

    Article Snippet: Brexpiprazole (Rexulti), developed by Otsuka and Lundbeck, grained FDA approval in July 2015.

    Techniques: Comparison, Concentration Assay, Activity Assay, Stripping Membranes

    Candidates and mechanism of action under development for the treatment of AD-related neuropsychiatric symptoms.

    Journal: International Journal of Molecular Sciences

    Article Title: Future Therapeutic Strategies for Alzheimer’s Disease: Focus on Behavioral and Psychological Symptoms

    doi: 10.3390/ijms252111338

    Figure Lengend Snippet: Candidates and mechanism of action under development for the treatment of AD-related neuropsychiatric symptoms.

    Article Snippet: Brexpiprazole (Rexulti), developed by Otsuka and Lundbeck, grained FDA approval in July 2015.

    Techniques: Activation Assay

    Comparison of mechanisms, symptoms, and therapeutic candidates of autism spectrum disorder and Alzheimer’s disease for social deficits.

    Journal: International Journal of Molecular Sciences

    Article Title: Future Therapeutic Strategies for Alzheimer’s Disease: Focus on Behavioral and Psychological Symptoms

    doi: 10.3390/ijms252111338

    Figure Lengend Snippet: Comparison of mechanisms, symptoms, and therapeutic candidates of autism spectrum disorder and Alzheimer’s disease for social deficits.

    Article Snippet: Brexpiprazole (Rexulti), developed by Otsuka and Lundbeck, grained FDA approval in July 2015.

    Techniques: Comparison, Isolation, Inhibition, Phospho-proteomics, Methylation, Migration, Transmission Assay

    New drugs for Alzheimer’s disease.

    Journal: Brain Sciences

    Article Title: Advancements in Pharmacological Treatment of Alzheimer’s Disease: The Advent of Disease-Modifying Therapies (DMTs)

    doi: 10.3390/brainsci14100990

    Figure Lengend Snippet: New drugs for Alzheimer’s disease.

    Article Snippet: Psychiatric Abnormalities Associated with AD , Rexulti , agitation , yes , high , Otsuka Pharmaceutical/Lundbeck , Full approval for marketing (2023).

    Techniques: Bioprocessing